India’s Most Admired Cardiac Surgeon Dr Hariawala Raises Protest
Over Artificial heart’s mockery
Healthcare Economist & Eminent Cardiac
Surgeon lashes out at marketing Gimmicks played over Artificial Heart by His
Contemporary Peers.
Monday, 24th September 2012, Mumbai,
Maharashtra : India’s much acclaimed &
World renowned Cardiac Surgeon & Healthcare Economist Dr Mukesh
Hariawala who recently shot to fame with
his stunning presentation on Is India prepared for a Artificial Heart Surgery
at his much anticipated Keynote Address that virtually stunned the audience who
had gathered in large numbers from the pharmaceutical Industry, Medical
Professionals at Pharmaleaders 5th Annual Pharmaceutical Leadership
Summit & Business Leadership Awards 2012 in a suburban hotel in Mumbai on
21st September 2012 organised by Pharmaleaders in association with
Pharmexcil, Ministry of Commerce to debate on the Healthcare Reforms in India. The
Summit felicitated top 33 performers in healthcare industry.
Satya Brahma, Chairman & Editor-In-Chief of Pharmaleaders opened up the debate with a scathing attack on the dual
standard of the Government to encourage domestic Pharma companies &
minimize the presence of the Multi-National Companies. Satya Said “ In an era
of Globalization, free trade & inter commercial relations which has brought
india to the world map, the attempt by the Government of India of not taking
the consensus on factors such as FDI, Reforms, Free Medicines policy &
Pricing are unfortunate & deplorable. Pharmaleaders, Asia’s Biggest voice
in healthcare Communications & Media debated on “Brand India”, Beyond
Generics - Leading with Resilience - Coming Back from Challenge and Heading
towards Super-power Status is going to be the business mantra of today’s
debate. Widely perceived by Industry’s Opinion Leaders & Analysts as the
Centre-Point of debating complex & serious issues, pharmaleaders platform
witnessed more than 20 top Industry Leaders deliberating on complex issues of this
sensitive Industry.
Questioning
the intent of the Government, Satya
Brahma stated “why is the health sector full of imperfections, despite huge
investments and increasing literacy rates?. There are a number of factors
responsible for it — lack of public financing, huge information asymmetry
between consumers and the providers, lack of coherence in policy formulation
between the Centre and States on the subject of healthcare and absence of
proper regulatory oversight. Healthcare infrastructure, insurance coverage,
disease prevalence, and patient population are the key fundamentals driving the
healthcare industry into the future the current density demand indicated
shortfall of hospital beds, doctors and nurses. The estimated requirement by
2025 is 1.75 million beds, 0.7 million doctors and 1.6 million nurse. Achieving
this target will require a total investment of US$ 77.9 billion. Pharma market
is expected to grow to US$ 54 billion. In 2010, it was cardiovascular and
diabetes which are the fastest growing and the two diseases will continue to
register 18 per cent and 20 per cent growth in terms of hospital admissions and
therapies”.
Dr Mukesh Hariawala, who was
felicitated the coveted India’s Most Admired Surgeon of India by Maharashtra
Governor K.Shankaranarayanan, said that india is on the move & unveiled
triple heart therapy in his keynote Address. To quote Dr Mukesh Hariawala “ Artificial Heart is not the scientific term but it
should be VAD ( mechanical ventricular assist device ) as in this operation the
native heart is not removed from the chest and replaced. Also Angiogenesis ,
Stem cells must be correctly explained that it is not a magic wand but will
play a synergistic role with conventional and proven bypass surgery. Finally,
unlike other Indian cardiac surgeons who want to indulge in sensationalism
journalism , I would like my image as a credible surgeon scientist whose
mission is to provide accurate meaningful educational information to the Indian
readership , doctors and patients. Dr Hariawala wanted to maintain peer respect
of fellow doctors and said he had no interest in becoming overnight medical
hero in India. Hariawala stated that he wanted to give back his expertise to motherland India which will
help poor patients with heart diseases. He countered Dr Ramakant Panda’s view
that “A tiny mechanized device weighing 400 grams may soon give a new lease of
life to more than 4 million people in the country who die of heart failure
every year. A Mumbai hospital has brought in the technology to implant an
artificial heart that takes over the functioning of the original heart and
promises to double the patient's life-expectancy. Artificial heart now in
India, price Rs 1 crore” as reported in Media”. Interestingly Dr panda was the
previous recipient of the Award Title as India’s Most Admired Surgeon at the
same platform in its 4th Annual Edition.
Dr Hariawala
unveiled 3 new revolutionary cardiac technologies , Dr Hariawala's pioneering
Triple Heart Therapy ( Angiogenesis + Stem Cells + Laser ) best done in a
" Hybrid Operation Suite " , VAD ( Ventricular Assist Device ) and
Non Invasive Shockwave Therapy in India. The FDA or CE mark approved VAD's,
which will be offered to patients as an alternative to Heart Transplantation,
has a cumulative worldwide Implantations record which has crossed 10,000. The
" Optimal VAD for India " would be one that has a good track record
of reliability, minimal complications and competitive shelf price. Elaborating
on the long life lithium ion battery operated VAD's which plays the role of a
Mechanical Artificial Heart, Dr Hariawala told ANI in an exclusive interview,
that VAD is only for patients who are in advanced stage heart failure and who
do not qualify as patients for routine angioplasty, stent or bypass surgery.
VAD patients following implantation will be able to ambulate and begin enjoying
an improved quality of life with certain restrictions, he said.
Storz
Medical's unique " MODULITH - SLC Shock Wave " Non - Invasive system
has an excellent record with CE certification that employs the principles of
" Therapeutic Angiogenesis ". This easy to deliver technology is
ultrasound image guided. The controlled targeted level of shock wave energy
stimulates the release of cellular growth factors like VEGF helping in
formation of micro blood vessels from pre existing ones. This resultant effect
is provision of a large pool of oxygen rich collateral vessel network which
supports circulation to the failing heart, thus giving early relief of angina
related symptoms. The advantage of this technology is negligible incidences of
procedural complications, and is best suited for most Indian patients who have
diabetes, diffused extensive non bypass-able coronary artery disease and who
are in need of repeat bypass surgery but are high risk subjects . The well
established EECP ( External Enhanced Counter Pulsation ) technology works on
the same principle using inferior extremity cuffs. Boston, US based Dr Mukesh
Hariawala is also a Visiting Honorary Cardiac Surgeon at Mumbai's Jaslok
Hospital. In addition to performing open heart surgery on many worldwide
celebrities, Dr Hariawala along with Dr John Wright had performed the first
Bypass operation in London on Prime Minister Dr Manmohan Singh in 1990
No comments:
Post a Comment